Nystatin
- Product NDC
- 21695-761
- 11-digit product format
- 216950761
- Labeler code
- 21695
- Product ID
- 21695-761_fb98a6b8-da0c-40f4-9e53-487b541865b5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nystatin
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Rebel Distributors Corp
- Application
- ANDA064022
- Marketing category
- ANDA
- Marketing start
- 1993-01-29
- Marketing end
- 0000-00-00
- Substance
- NYSTATIN
- Active strength
- 100000 mg/g
- Pharmacologic classes
- Polyene Antifungal [EPC],Polyenes [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 21695-761 | I | Inactivated by FDA | 2026-08-03 | ||
| excluded package | package | 21695-761 | 21695-761-15 | I | Inactivated by FDA | 2026-08-03 | |
| excluded package | package | 21695-761 | 21695-761-30 | I | Inactivated by FDA | 2026-08-03 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A064022-001 | NYSTATIN | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A064022-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A064022-001 | NYSTATIN | 100,000 UNITS/GM | CREAM / TOPICAL | AT | RS | 1993-01-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A064022-001 | AT | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nystatin | NYSTATIN | Sun Pharmaceutical Industries, Inc. | 4d845b3f-ca26-4c47-b424-b6d783cc10e5 | 2025-07-03 | Adverse reactions | 064022 ANDA064022 |
| Nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | cf6b7c68-7769-1808-e053-2995a90aa426 | 2025-02-10 | Adverse reactions | 064022 ANDA064022 |
| NYSTATIN | NYSTATIN | DIRECT RX | cd387929-5b72-e3c0-e053-2a95a90adb22 | 2025-01-20 | Adverse reactions | 064022 ANDA064022 |
| Nystatin | NYSTATIN | NuCare Pharmaceuticals,Inc. | 57825c04-dcb5-b76d-e053-2991aa0a4c1d | 2024-08-14 | Adverse reactions | 064022 ANDA064022 |
| Nystatin | NYSTATIN | Proficient Rx LP | 5ef15e1c-66dc-4858-8552-d83e42c3883e | 2019-11-01 | Adverse reactions | 064022 ANDA064022 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e29fe634-dc25-094c-c77f-5d09c3eceb3e | Product name | 5 | 20260107 |
| e57b6340-9387-3f9a-7307-511c81791375 | Product name | 3 | 20221214 |
| 544f8e8d-6389-eeeb-9586-aa447c08dcc7 | Product name | 5 | 20210614 |
| 1629e00f-54fb-4a43-8306-b58442b23902 | Product name | 9 | 20200430 |
| 854ec07b-1cd7-a5db-235a-7aa24d3cf97a | Product name | 3 | 20180628 |
| 19b9f4c1-15e9-edcc-4c16-f01ecfb5c549 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 21695-761-15 | 2019-09-24 | C162847 | 48780-1 | 934fe258-487e-48b1-e053-8cdaa90a720a | Nystatin Cream USP, 100,000 units per gram |
| 21695-761-30 | 2019-09-24 | C162847 | 48780-1 | 934fe258-487e-48b1-e053-8cdaa90a720a | Nystatin Cream USP, 100,000 units per gram |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21695-761-15 | Nystatin | 15 g in 1 TUBE | CREAM | 15 | 1 | |
| 21695-761-15 | Nystatin | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 21695-761-30 | Nystatin | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 21695-761-30 | Nystatin | 30 g in 1 TUBE | CREAM | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 21695-761-15 | GM - Gram | 21695-761 | b5aaac98-43a4-4919-9a1e-74408bbaa008 | 1 | 2012-07-24 |
| 21695-761-30 | GM - Gram | 21695-761 | 3246afc3-3809-4ac8-b4ed-6770e5e0b180 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
Packages#
| Package NDC | 11-digit format | Description | Units | Status |
|---|---|---|---|---|
| 21695-761-15 | 21695076115 | 15 g in 1 TUBE | 15 g | Historical |
| 21695-761-30 | 21695076130 | 1 in 1 CARTON | Historical |